Your browser is no longer supported. Please, upgrade your browser.
CNC Centene Corporation monthly Stock Chart
Centene Corporation
IndexS&P 500 P/E19.39 EPS (ttm)2.86 Insider Own0.70% Shs Outstand579.19M Perf Week-9.36%
Market Cap31.74B Forward P/E9.63 EPS next Y5.75 Insider Trans-8.45% Shs Float568.74M Perf Month-6.69%
Income1.56B PEG1.42 EPS next Q0.96 Inst Own95.10% Short Float1.51% Perf Quarter-7.26%
Sales91.58B P/S0.35 EPS this Y39.10% Inst Trans-0.85% Short Ratio2.41 Perf Half Y0.56%
Book/sh43.26 P/B1.28 EPS next Y18.03% ROA3.00% Target Price85.08 Perf Year28.47%
Cash/sh25.07 P/C2.21 EPS next 5Y13.70% ROE8.50% 52W Range41.62 - 74.70 Perf YTD-11.87%
Dividend- P/FCF16.55 EPS past 5Y23.10% ROI4.90% 52W High-25.82% Beta0.57
Dividend %- Quick Ratio1.20 Sales past 5Y35.10% Gross Margin18.40% 52W Low33.12% ATR1.96
Employees56600 Current Ratio1.20 Sales Q/Q51.00% Oper. Margin2.90% RSI (14)37.57 Volatility3.81% 3.16%
OptionableYes Debt/Eq0.67 EPS Q/Q74.00% Profit Margin1.70% Rel Volume1.09 Prev Close54.30
ShortableYes LT Debt/Eq0.67 EarningsOct 27 BMO Payout0.00% Avg Volume3.56M Price55.41
Recom1.60 SMA20-5.36% SMA50-10.63% SMA200-11.56% Volume3,879,666 Change2.04%
Sep-22-20Downgrade Stephens Overweight → Equal-Weight
Jul-01-20Initiated SVB Leerink Outperform $78
Feb-05-20Upgrade JP Morgan Neutral → Overweight $88
Feb-03-20Resumed Evercore ISI Outperform $90
Jan-28-20Reiterated Bernstein Outperform $84 → $103
Jan-06-20Upgrade Wolfe Research Peer Perform → Outperform
Sep-12-19Initiated Deutsche Bank Buy
May-10-19Upgrade Citigroup Neutral → Buy $69
Jan-14-19Initiated Stephens Overweight $147
Oct-24-18Upgrade Leerink Partners Mkt Perform → Outperform
Jul-18-18Resumed Citigroup Neutral $147
Dec-18-17Reiterated Jefferies Buy $112 → $115
Sep-13-17Reiterated Leerink Partners Mkt Perform $78 → $90
Jun-07-17Initiated Morgan Stanley Overweight
May-22-17Downgrade JP Morgan Overweight → Neutral
Apr-05-17Initiated Deutsche Bank Buy $84
Mar-23-17Downgrade Citigroup Buy → Neutral
Feb-08-17Reiterated Barclays Overweight $75 → $79
Feb-07-17Resumed Cantor Fitzgerald Overweight $85
Jan-04-17Initiated Piper Jaffray Overweight
Sep-24-20 10:54AM  
Sep-23-20 06:07PM  
Sep-21-20 04:33PM  
Sep-17-20 08:00AM  
Sep-15-20 10:57AM  
Sep-14-20 07:00AM  
Sep-13-20 09:41AM  
Sep-11-20 07:00AM  
Sep-10-20 08:00AM  
Sep-02-20 08:53AM  
Sep-01-20 05:45PM  
Aug-31-20 08:36AM  
Aug-28-20 03:04PM  
Aug-27-20 11:31AM  
Aug-26-20 10:49AM  
Aug-24-20 07:00AM  
Aug-21-20 03:13PM  
Aug-19-20 06:49PM  
Aug-18-20 12:07PM  
Jul-30-20 07:46PM  
Jul-29-20 11:41AM  
Jul-28-20 02:30PM  
Jul-27-20 03:18PM  
Jul-24-20 12:57PM  
Jul-21-20 12:31PM  
Jul-16-20 12:08PM  
Jul-15-20 12:59PM  
Jul-14-20 10:13AM  
Jul-13-20 05:51PM  
Jul-09-20 05:55PM  
Jul-06-20 10:27AM  
Jul-03-20 11:30AM  
Jul-02-20 05:13PM  
Jul-01-20 01:00PM  
Jun-30-20 11:50AM  
Jun-17-20 06:26PM  
Jun-16-20 08:00AM  
Jun-15-20 03:46PM  
Jun-13-20 12:54PM  
Jun-12-20 05:04PM  
Jun-09-20 08:00AM  
Jun-08-20 07:00AM  
Jun-05-20 10:50AM  
Jun-01-20 02:54PM  
May-29-20 12:47PM  
May-28-20 11:50AM  
May-27-20 07:00AM  
May-26-20 01:33PM  
May-22-20 06:04PM  
May-20-20 04:04PM  
May-18-20 03:37PM  
May-17-20 08:35AM  
May-16-20 12:51PM  
May-15-20 08:45PM  
May-14-20 03:25PM  
May-12-20 06:30PM  
May-08-20 07:14AM  
May-05-20 11:50AM  
May-04-20 09:01AM  
May-01-20 08:00AM  
Apr-29-20 02:36PM  
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs; staffing services; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burdick Kenneth AEVP, Markets & ProductsAug 10Sale63.3335,0002,216,550908,341Aug 11 06:09 PM
Burdick Kenneth AEVP, Markets & ProductsJul 30Sale65.9835,0002,309,300943,341Jul 31 04:34 PM
DITMORE ROBERT KDirectorJul 30Sale65.3433,3332,177,978692,660Jul 31 04:35 PM
AYALA ORLANDODirectorJul 30Sale65.369,878645,626151,052Jul 31 04:35 PM
Thompson Tommy GDirectorJul 01Sale64.131,50096,195162,396Jul 02 06:43 PM
AYALA ORLANDODirectorJun 22Sale63.8730,0001,916,100160,930Jun 23 07:03 PM
GEPHARDT Richard ADirectorJun 19Sale65.2814,749962,81560,262Jun 23 07:02 PM
GEPHARDT Richard ADirectorJun 16Sale65.0210,401676,27375,011Jun 18 06:05 PM
Burdick Kenneth AEVP, Markets & ProductsJun 08Sale65.9335,0002,307,550978,341Jun 10 05:51 PM
DITMORE ROBERT KDirectorJun 08Sale65.3133,3332,176,978725,340Jun 10 05:52 PM
BURKHALTER BRANDYEVP, Chief Operating OfficerJun 08Sale67.008,000536,000330,782Jun 10 05:51 PM
ROBERTS JOHN RDirectorMay 18Sale70.0010,000700,00027,504May 20 07:12 PM
Burdick Kenneth AEVP, Markets & ProductsMay 11Sale67.0935,0002,348,1501,013,341May 12 06:13 PM
Burdick Kenneth AEVP, Markets & ProductsApr 30Sale66.3235,0002,321,2001,048,341May 01 06:18 PM
Schwaneke Jeffrey A.EVP, CFOApr 09Sale68.007,500510,000405,624Apr 10 06:45 PM
Burdick Kenneth AEVP, Markets & ProductsApr 08Sale64.3220,3141,306,5961,083,341Apr 09 05:53 PM
Burdick Kenneth AEVP, Markets & ProductsApr 07Sale62.2214,686913,7631,103,655Apr 09 05:53 PM
Thompson Tommy GDirectorApr 06Sale58.001,50087,000380,928Apr 08 05:58 PM
NEIDORFF MICHAEL FChairman, President & CEOMar 04Option Exercise28.5112,500356,3757,087,732Mar 04 04:00 PM
Thompson Tommy GDirectorMar 02Sale53.4250026,710381,851Mar 04 05:34 PM
Thompson Tommy GDirectorFeb 06Sale65.8150032,905382,351Feb 10 07:37 PM
DITMORE ROBERT KDirectorFeb 06Sale65.3130,0001,959,300754,673Feb 10 07:37 PM
Thompson Tommy GDirectorJan 02Sale62.9850031,490382,851Jan 03 06:15 PM
BROOKS MARK JEVP, Chief Information OfficerDec 26Sale63.342,947186,663145,742Dec 27 05:32 PM
Williamson Keith HEVP, Secr. & General CounselDec 17Sale59.1311,000650,430176,376Dec 19 05:48 PM
DITMORE ROBERT KDirectorDec 17Sale59.4930,0001,784,700783,889Dec 19 05:45 PM
NEIDORFF MICHAEL FChairman, President & CEONov 25Sale60.23100,0006,023,0006,913,390Nov 26 05:17 PM
Hunter Jesse NEVP, M&A & Chief Strategy OfcrNov 18Sale60.0020,0001,200,000443,640Nov 19 06:13 PM
NEIDORFF MICHAEL FChairman, President & CEONov 15Sale57.0075,0004,275,0007,013,390Nov 19 06:12 PM
DITMORE ROBERT KDirectorOct 30Sale53.2510,981584,738813,889Oct 31 05:13 PM
DITMORE ROBERT KDirectorOct 29Sale50.0149,0192,451,440824,870Oct 31 05:13 PM